Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Mayo Clin Proc Innov Qual Outcomes ; 4(6): 775-785, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33283161

RESUMEN

Takotsubo syndrome (TTS), also known as stress cardiomyopathy and broken heart syndrome, is a neurocardiac condition that is among the most dramatic manifestations of psychosomatic disorders. This paper is based on a systematic review of TTS and stress cardiomyopathy using a PubMed literature search. Typically, an episode of severe emotional or physical stress precipitates regions of left ventricular hypokinesis or akinesis, which are not aligned with a coronary artery distribution and are out of proportion to the modest troponin leak. A classic patient with TTS is described; one who had chest pain and dyspnea while watching an anxiety-provoking evening news program on the coronavirus disease 2019 (COVID-19) pandemic. An increase in the incidence of TTS appears to be a consequence of the COVID-19 pandemic, with the TTS incidence rising 4.5-fold during the COVID-19 pandemic even in individuals without severe acute respiratory syndrome coronavirus 2 infection. Takotsubo syndrome is often mistaken for acute coronary syndrome because they both typically present with chest pain, electrocardiographic changes suggesting myocardial injury/ischemia, and troponin elevations. Recent studies report that the prognosis for TTS is similar to that for acute myocardial infarction. This review is an update on the mechanisms underlying TTS, its diagnosis, and its optimal management.

2.
J Alzheimers Dis ; 78(2): 619-626, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33016914

RESUMEN

BACKGROUND: Alzheimer's disease (AD) is increasingly prevalent and over 99% of drugs developed for AD have failed in clinical trials. A growing body of literature suggests that potent inhibitors of tumor necrosis factor-α (TNF-α) have potential to improve cognitive performance. OBJECTIVE: In this review, we summarize the evidence regarding the potential for TNF-α inhibition to prevent AD and improve cognitive function in people at risk for dementia. METHODS: We conducted a literature review in PubMed, screening all articles published before July 7, 2019 related to TNF blocking agents and curcumin (another TNF-α inhibitor) in the context of AD pathology. The keywords in the search included: AD, dementia, memory, cognition, TNF-α, TNF inhibitors, etanercept, infliximab, adalimumab, golimumab, and curcumin. RESULTS: Three large epidemiology studies reported etanercept treated patients had 60 to 70% lower odds ratio (OR) of developing AD. Two small-randomized control trials (RCTs) demonstrated an improvement in cognitive performance for AD patients treated with etanercept. Studies using animal models of dementia also reported similar findings with TNF blocking agents (etanercept, infliximab, adalimumab, Theracurmin), which appeared to improve cognition. A small human RCT using Theracurmin, a well-absorbed form of curcumin that lowers TNF-α, showed enhanced cognitive performance and decreased brain levels of amyloid-ß plaque and tau tangles. CONCLUSION: TNF-α targeted therapy is a biologically plausible approach to the preservation of cognition, and warrants larger prospective RCTs to further investigate potential benefits in populations at risk of developing AD.


Asunto(s)
Enfermedad de Alzheimer/prevención & control , Enfermedad de Alzheimer/psicología , Anticuerpos Monoclonales Humanizados/uso terapéutico , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Adalimumab/farmacología , Adalimumab/uso terapéutico , Enfermedad de Alzheimer/metabolismo , Animales , Anticuerpos Monoclonales/farmacología , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales Humanizados/farmacología , Ensayos Clínicos como Asunto/métodos , Curcumina/farmacología , Curcumina/uso terapéutico , Etanercept/farmacología , Etanercept/uso terapéutico , Humanos , Factor de Necrosis Tumoral alfa/metabolismo
3.
J Am Coll Cardiol ; 76(12): 1484-1493, 2020 09 22.
Artículo en Inglés | MEDLINE | ID: mdl-32943166

RESUMEN

As opportunistic omnivores, humans are evolutionarily adapted to obtain calories and nutrients from both plant and animal food sources. Today, many people overconsume animal products, often-processed meats high in saturated fats and chemical additives. Alternatively, strict veganism can cause nutritional deficiencies and predispose to osteopenia, sarcopenia, and anemia. A logical compromise is a plant-rich diet with fish/seafood as principal sources of animal food. This paper reviews cumulative evidence regarding diet and health, incorporating data from landmark clinical trials of the Mediterranean diet and recommendations from recent authoritative guidelines, to support the hypothesis that a Pesco-Mediterranean diet is ideal for optimizing cardiovascular health. The foundation of this diet is vegetables, fruits, nuts, seeds, legumes, whole grains, and extra-virgin olive oil with fish/seafood and fermented dairy products. Beverages of choice are water, coffee, and tea. Time-restricted eating is recommended, whereby intermittent fasting is done for 12 to 16 h each day.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Dieta Mediterránea , Ayuno , Alimentos Marinos , Fabaceae , Humanos , Nueces , Aceite de Oliva
4.
Mo Med ; 117(4): 355-361, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32848273

RESUMEN

A wealth of scientific literature backs the unique therapeutic benefits of exercise for quality of life, cardiovascular (CV) health, and longevity. Consequently, many have assumed that more exercise is always better. However, chronic excessive endurance exercise might adversely impact CV health. Ultra-endurance races can inflict acute myocardial damage, as evidenced by elevations in troponin and brain natriuretic peptide. Moreover, sudden cardiac arrest occurs more often in marathons and triathlons than in shorter races. Veteran endurance athletes often show abnormal cardiac remodeling with increased risk for myocardial fibrosis and coronary calcification. Chronic excessive exercise has been consistently associated with increased risks of atrial fibrillation (AF), and along with some attenuation of longevity benefits. The optimal dose of exercise remains unknown and probably differs among individuals. Current studies suggest that 2.5 to 5 hours/week of moderate or vigorous physical activity will confer maximal benefits; >10 hours/week may reduce these health benefits.


Asunto(s)
Interpretación Estadística de Datos , Terapia por Ejercicio/normas , Longevidad , Sistema Cardiovascular/fisiopatología , Terapia por Ejercicio/métodos , Humanos , Mortalidad/tendencias , Factores de Riesgo
5.
J Am Coll Cardiol ; 76(7): 858-866, 2020 08 18.
Artículo en Inglés | MEDLINE | ID: mdl-32792083

RESUMEN

Although the prevalence of attention-deficit/hyperactivity disorder (ADHD) has been stable over the past 3 decades, prescriptions of sympathomimetic stimulants have steadily increased in the United States. This study consisted of a systematic review of PubMed articles screened for ADHD medications and potential cardiovascular toxicity as well as nondrug strategies for managing ADHD. The cumulative body of data showed that ADHD medications cause modest elevations in resting heart rate and blood pressure. Other adverse effects reported with ADHD stimulants included arrhythmia, nonischemic cardiomyopathy, Takotsubo cardiomyopathy, and sudden death. However, such reports did not imply causation, and there was a paucity of randomized trial evidence addressing long-term safety of ADHD medications, particularly among adults. Further studies are essential to clarify the risks and benefits of ADHD stimulant medications and to explore nonpharmacological options, including regular exercise and omega-3 fatty acids, which could be helpful for improving ADHD symptoms.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad , Enfermedades Cardiovasculares , Estimulantes del Sistema Nervioso Central/farmacología , Trastorno por Déficit de Atención con Hiperactividad/tratamiento farmacológico , Trastorno por Déficit de Atención con Hiperactividad/epidemiología , Enfermedades Cardiovasculares/inducido químicamente , Enfermedades Cardiovasculares/epidemiología , Sistema Cardiovascular/efectos de los fármacos , Humanos
7.
Cureus ; 11(10): e5960, 2019 Oct 22.
Artículo en Inglés | MEDLINE | ID: mdl-31803549

RESUMEN

The recommended amount of iodide consumption for the majority of adults is approximately 150 mcg per day. During a computed tomography scan, patients can receive 14 to 35 million mcg of iodinated contrast. A 46-year-old African female with no known prior thyroid disease presented with dyspnea and tachycardia. She underwent computed tomography angiogram of the chest to rule out pulmonary embolism. She had evidence of hyperthyroidism four hours after receiving iodinated contrast. We presumed that her hyperthyroidism was a consequence of the Jod-Basedow phenomenon due to an underlying multinodular goiter that was later discovered.

8.
Cureus ; 11(4): e4512, 2019 Apr 20.
Artículo en Inglés | MEDLINE | ID: mdl-31259121

RESUMEN

Accidental hypothermia and thrombosis are rarely associated and encountered. A 66-year-old male and 62-year-old male were both admitted with accidental hypothermia. Patient 1 had a rectal temperature of 28.5 °Celcius (C). After 1 day of hospitalization, he developed worsening shortness of breath due to worsening pulmonary edema. Further investigation with echocardiogram showed large left ventricular thrombi as well and global hypokinesis and apical akinesis. Patient 2 had a rectal temperature of 28.5 °C, he was also discovered to have a multifactorial shock. Echocardiogram for shock evaluation showed small apical thrombus as well as global hypokinesis. Hypothermia has been associated with hypocoagulability rather than hypercoagulability secondary to platelet dysfunction and clotting factor enzyme derangements. Moreover, hypothermia has also been associated with myocardial dysfunction that could have predisposed the development of intracardiac thrombi. Further research needs to be done to help better understand these possible association.

9.
Prog Cardiovasc Dis ; 58(5): 529-36, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26892393

RESUMEN

Coronary artery calcium (CAC), identified via low-radiation, non-contrast computed tomography of the heart, quantifies the burden of calcified coronary atherosclerosis. This modality is highly useful for cardiovascular (CV) risk stratification among individuals without known coronary heart disease (CHD), especially for those at intermediate risk. The presence of CAC is associated with up to a 10-fold higher risk of adverse CV events, even after fully adjusting for the standard CV risk factors. In fact, the CAC score is among the strongest clinically available predictors of future risk of adverse CV events among primary prevention patients. Additionally, the absence of CAC in asymptomatic individuals confers a very low risk of CV events. Even in the presence of a benign CV risk factor profile and normal cardiac stress test, a very high CAC score portends a high risk of adverse CV events. On the other hand, a CAC score of zero is associated with a low CHD risk despite significant CV risk factor profiles. CAC scoring is a quick, low-cost screening tool to help risk-stratify patients and identify those likely to benefit from aggressive preventive treatments (such as high-intensity statin therapy, ezetimibe, PCSK9 inhibitors, and aspirin) and to identify those likely who warrant close monitoring. Moreover, individuals with a zero CAC score may be at low enough risk to avoid or defer daily aspirin therapy and pharmacological therapy for cholesterol management, and instead work on therapeutic lifestyle changes. An abnormal CAC score may also lead to better adherence to pharmacological regimens and suggested lifestyle changes.


Asunto(s)
Angiografía por Tomografía Computarizada , Angiografía Coronaria/métodos , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Vasos Coronarios/diagnóstico por imagen , Técnicas de Apoyo para la Decisión , Calcificación Vascular/diagnóstico por imagen , Enfermedades Asintomáticas , Enfermedad de la Arteria Coronaria/epidemiología , Enfermedad de la Arteria Coronaria/terapia , Humanos , Estimación de Kaplan-Meier , Placa Aterosclerótica , Valor Predictivo de las Pruebas , Pronóstico , Medición de Riesgo , Factores de Riesgo , Prevención Secundaria/métodos , Índice de Severidad de la Enfermedad , Calcificación Vascular/epidemiología , Calcificación Vascular/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...